BioSpace News Archive

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce a new private placement of $325,125, the sale of approximately 2.7 Million Units priced at $0.12 each.

Immunis, Inc., a private biotech company creating novel cellular secretome therapies for age and disease-related immune decline, is delighted to have Professor Irina Conboy on its Scientific Advisory Board.

Theranica, a neuromodulation therapeutics company, is exhibiting and presenting at the upcoming 52nd Annual Child Neurology Society Meeting (CNS)(Booth #209), where they will present Nerivio®, the first and only dual-use (acute and preventive) migraine neuroband purpose-built for adolescents with migraine disease.

The Lung Cancer Research Foundation announces its newest board chair, Colleen Conner Ziegler.

Spexis AG, a clinical-stage biopharmaceutical company focused on rare diseases and oncology, announced that the company has appointed Gonçalo Bernardes, PhD, as acting Head of Chemical Biology.